Declining value of alanine aminotransferase in screening blood donors: missed opportunities
暂无分享,去创建一个
[1] M. Busch,et al. Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors , 1996, Transfusion.
[2] S. Kleinman,et al. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study , 1995, Transfusion.
[3] R. Gambino. Lost opportunity cost of surrogate markers in post-transfusion hepatitis , 1995, The Lancet.
[4] R. Purcell,et al. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. , 1981, JAMA.
[5] R. Kahn,et al. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. , 1981, The New England journal of medicine.
[6] J. S. Ladue,et al. DETECTION OF HEPATITIS CARRIERS BY SERUM GLUTAMIC OXALACETIC TRANSAMINASE ACTIVITY , 1959 .
[7] M. Blajchman,et al. Do surrogate tests improve the safety of the blood supply? , 1995, Vox sanguinis.